Oracle Corp (ORCL) Shares Declined While Klingenstein Fields & Co LLC Increased Its Stake

April 16, 2018 - By Robert Reynolds

Oracle Corporation (NYSE:ORCL) Corporate LogoBig Money Sentiment increased to 1.15 in 2017 Q4. It has change of 0.02, from 2017Q3’s 1.13. The ratio is positive due to ORCL positioning: 80 sold and 488 reduced. 126 funds amassed positions and 526 increased positions. Investors holded 2.32 billion in 2017Q3 but now own 2.29 billion shares or 1.37% less. Jacobs And Company Ca reported 22,144 shs. Ubs Oconnor Limited Com reported 34,698 shs stake. Segall Bryant Hamill Limited Liability owns 175,447 shs. Eads & Heald Invest Counsel invested in 1.17% or 42,123 shs. Moreover, Oak Associates Oh has 1.41% invested in Oracle Corporation (NYSE:ORCL). Davidson Investment Advisors holds 16,017 shs. Stack Mngmt holds 865,075 shs or 4.11% of its capital. Piedmont Invest Advsr Ltd Liability invested 0.74% in Oracle Corporation (NYSE:ORCL). General American Investors Inc invested 1.12% in Oracle Corporation (NYSE:ORCL). First Dallas Securities reported 0.13% stake. Essex Finance Services reported 11,176 shs or 0.13% of all its holdings. Flossbach Von Storch Ag holds 0.68% in Oracle Corporation (NYSE:ORCL) or 1.51 million shs. Peddock Capital Advisors Ltd Liability holds 0.09% or 3,752 shs in its capital. Marathon Asset Mngmt Ltd Liability Partnership holds 4.49 million shs or 3.27% of its capital. Lee Danner Bass accumulated 78,265 shs.

According to 2017Q4 SEC filling the Klingenstein Fields & Co Llc rose its holdings in Oracle Corp (ORCL) by 116.59%. By buying 223,385 shares Klingenstein Fields & Co Llc made the stock sank with 4.18%. The prepackaged software company at the end of 2017Q4 was priced at $19.62 million. It’s up from 191,591 at the end of the previous reported quarter. Now it had 414,976 shares held by the institutional investor . For a total of 132,463 shares it reduced its holding in Cvs Health Corp (NYSE:CVS) by 121,441 shares in the quarter, and has cut its stake in Xilinx Inc (NASDAQ:XLNX).

Oracle Corporation (NYSE:ORCL) Ratings Coverage

In total 19 analysts cover Oracle Corp (NYSE:ORCL). “Buy” rating has 13, “Sell” are 0, while 6 are “Hold”. 68% are bullish. 22 are the (NYSE:ORCL)’s analyst reports since October 17, 2017 according to StockzIntelligence Inc. In Friday, December 15 report Raymond James maintained the stock with “Buy” rating. The company rating was maintained by Canaccord Genuity on Friday, December 15. On Thursday, March 15 RBC Capital Markets maintained Oracle Corporation (NYSE:ORCL) with “Hold” rating. The stock rating was downgraded by RBC Capital Markets to “Sector Perform” on Friday, December 15. On Wednesday, January 3 the firm has “Overweight” rating given by Morgan Stanley. On Tuesday, October 17 the firm has “Buy” rating by Jefferies given. The company rating was downgraded by KeyBanc Capital Markets on Tuesday, March 20. On Thursday, October 19 Stifel Nicolaus maintained the shares of ORCL in report with “Buy” rating. The company rating was maintained by Cowen & Co on Monday, October 23. In Tuesday, March 20 report Bank of America downgraded the stock to “Neutral” rating.

Oracle Corporation (NYSE:ORCL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.